Market Access Consulting

Knowledge and perspective to develop high-impact market access strategies.

Services & Products

  • Webinars

    Webinar

    Incorporating Patient Preferences into Product Development and Value Communication

    Presenters: Kevin Marsh, PhD, Executive Director, Senior Research Scientist, Modeling & Simulation, Evidera; John F. P. Bridges, PhD, Associate Professor, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health

    FIRST OF 3-PART SERIES ON PATIENT PREFERENCE

    Additional Info
    Contact us for slides
    Recording

    Webinar

    Adaptive Pathways and HTAs: Trade-offs in Implementation between Speed and Uncertainty

    Presenters: Susanne Michel, MD, European Practice Leader, Payer Strategy; Yvonne Beatrice Boehler, MD, MBA, Prof. TH Koln University; Agnes Benedict, MA, MSc, Sr. Research Scientist, M&S and Exec. Dir. Center of Excellence - HE; Noemi Muszbek, MA, MSc, Sr. Research Scientist, M&S

    Additional Info
    Contact us for slides

    Webinar

    The Early Market Access Armamentarium – Planning effective Early Market Access in Europe

    Presenters: Susanne Michel, MD, Payer Strategy Group, Evidera; Paul Miller, Member NICE Appraisal Committee

    Additional Info
    Contact us for slides
    See More
  • White Papers

    Whitepaper

    Using Real-World Evidence in Payer Negotiations: What's in Your Playbook?

    Authors: Ariel Berger, MPH, Senior Research Scientist and Director, US Database Analytics, Real-World Evidence; Cheryl Ball, BSFS, Vice President, General Manager, Market Access Consulting, Evidera

    Year: 2017

    View

    Whitepaper

    Do Payers Find Value in Innovative Trial Designs?

    Authors: David Pruce, MRPharmS, Senior Principal, Market Access Consulting, Evidera; Susanne Michel, MD, Vice President and Practice Lead, Market Access Consulting, and Executive Director, Center of Excellence for Market Access, Evidera; Panteli Theocharous, FIBMS, PhD, FRCPath, Vice President, Global Product Development Haematology/Oncology, PPD

    Year: 2017

    View

    Whitepaper

    Understanding Payer Sensitivities when Considering the Use of Surrogate Endpoints to Substantiate Clinical Value Propositions

    Authors: Andrew Satherley, MSc, Senior Consultant, Market Access Consulting; Eric Chang, PharmD, Consultant, Market Access Consulting; Sonika Awasthy, MSc, Senior Business Analyst, Market Access Consulting; Susanne Michel, MD, Vice President and Practice Lead, Market Access Consulting and Executive Director, Center of Excellence for Market Access, Evidera

    Year: 2017

    View

    Whitepaper

    EMA-HTA Parallel Scientific Advice: Early Dialogue to Support Marketing Authorization and Market Access

    Authors: Kirsten Messmer, PhD, RAC, Principal Regulatory Affairs Specialist, PPD; James McCormick, PhD, Senior Director Regulatory Affairs, PPD; Lina Sladkeviciute, MSc, Managing Consultant, Market Access Consulting, Evidera

    Year: 2017

    View
    See More
  • Presentations

    Issue Panel

    IP2: Are We Ready for a Cure? Key Value Demonstration and Policy Considerations for the New Wave of Potentially Curative Therapies

    ISPOR 21st Annual International Meeting – 2016:

    Washington, DC, USA
    21-May-2016

    Authors/Presenters: Faulkner E, Thomas S, Syrek-Jensen T, Daniel G

    Year: 2016

    Poster

    PHP33: Surrogate Endpoints - Can Pricing and Reimbursement Align Across Markets - Or Will the Same Outcome Continue To Be Rewarded Differently for Pricing and Reimbursement?

    ISPOR 21st Annual International Meeting – 2016:

    Washington, DC, USA
    21-May-2016

    Authors/Presenters: Chang E, Satherley A, Awasthy S, Michel S

    Year: 2016

    View

    Poster

    PMD82: 3D Printing is Revolutionizing the Medical Devices World, But Are Payers Ready?

    ISPOR 21st Annual International Meeting – 2016:

    Washington, DC, USA
    21-May-2016

    Authors/Presenters: Nuryyeva E

    Year: 2016

    View
    See More
  • Fact Sheets

    Fact Sheet

    Market Access Consulting Services
    Download

    Fact Sheet

    Payer Expectations of Surrogate Endpoints in Pricing and Reimbursement
    Download

    Fact Sheet

    Navigating the Maze – Market Access for Medical Devices
    Download

    Fact Sheet

    Navigating the Maze – Market Access for Medical Devices: BRAZIL
    Download

    Fact Sheet

    Navigating the Maze – Market Access for Medical Devices: FRANCE
    Download

    Fact Sheet

    Navigating the Maze – Market Access for Medical Devices: GERMANY
    Download

    Fact Sheet

    Navigating the Maze – Market Access for Medical Devices: ITALY
    Download

Product success hinges on more than regulatory approval. Payers require evidence and arguments to be convinced of the incremental clinical improvement and economic value of new treatments. This is particularly challenging in environments where many therapeutic options and emerging comparators exist. By working closely with payers to understand the drivers of value and their expectations of price, our team of experts develops robust market access strategies and pricing recommendations.

A best-in-class global payer network and deep understanding of healthcare systems and payers, along with the commercial insights to steer strategy, allow us to support clients across the product life cycle. We conduct early due diligence for potential asset acquisitions, through to addressing price and reimbursement challenges for compounds later in the commercial cycle. We also test, refine and validate value messages with relevant stakeholders to ensure the product value story is built and communicated in the most effective way.

Through two decades of pricing, reimbursement and market access consulting, we have:

  • Built a network of 2,000+ payer experts and advisors worldwide
  • Acquired pricing, reimbursement and market access expertise in 45+ countries
  • Conducted ~35,000 payer interviews entirely in-house
  • Amassed knowledge and experience across all major therapeutic areas

Offerings

International Payer Advisory Boards

Explore key market access hypotheses with payers and advisors from around the world regarding product profile and evidence requirements.

Landscape Review and Market Assessment

Gather detailed information on the payer environment to inform market access planning.

Comprehensive Global Pricing and Market Access Strategy

Develop strategic recommendations for optimal global price and data generation activities; develop likely payer recommendations including restrictions.

Rapid Assessment of Payers’ Perspectives on In-licensed Drugs (RAPPID®)

Support business development investment decisions with global pricing input for due diligence.

Pricing and Market Access Workshops

Provide technical training and testing challenges, including contracting, tendering and negotiation and support for local affiliates with the opportunity to test their negotiation strategies live with payers from their market.

Market Access Consulting Experts

Services & Products

  • Webinars

    Webinar

    Incorporating Patient Preferences into Product Development and Value Communication

    Presenters: Kevin Marsh, PhD, Executive Director, Senior Research Scientist, Modeling & Simulation, Evidera; John F. P. Bridges, PhD, Associate Professor, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health

    FIRST OF 3-PART SERIES ON PATIENT PREFERENCE

    Additional Info
    Contact us for slides
    Recording

    Webinar

    Adaptive Pathways and HTAs: Trade-offs in Implementation between Speed and Uncertainty

    Presenters: Susanne Michel, MD, European Practice Leader, Payer Strategy; Yvonne Beatrice Boehler, MD, MBA, Prof. TH Koln University; Agnes Benedict, MA, MSc, Sr. Research Scientist, M&S and Exec. Dir. Center of Excellence - HE; Noemi Muszbek, MA, MSc, Sr. Research Scientist, M&S

    Additional Info
    Contact us for slides

    Webinar

    The Early Market Access Armamentarium – Planning effective Early Market Access in Europe

    Presenters: Susanne Michel, MD, Payer Strategy Group, Evidera; Paul Miller, Member NICE Appraisal Committee

    Additional Info
    Contact us for slides
    See More
  • White Papers

    Whitepaper

    Using Real-World Evidence in Payer Negotiations: What's in Your Playbook?

    Authors: Ariel Berger, MPH, Senior Research Scientist and Director, US Database Analytics, Real-World Evidence; Cheryl Ball, BSFS, Vice President, General Manager, Market Access Consulting, Evidera

    Year: 2017

    View

    Whitepaper

    Do Payers Find Value in Innovative Trial Designs?

    Authors: David Pruce, MRPharmS, Senior Principal, Market Access Consulting, Evidera; Susanne Michel, MD, Vice President and Practice Lead, Market Access Consulting, and Executive Director, Center of Excellence for Market Access, Evidera; Panteli Theocharous, FIBMS, PhD, FRCPath, Vice President, Global Product Development Haematology/Oncology, PPD

    Year: 2017

    View

    Whitepaper

    Understanding Payer Sensitivities when Considering the Use of Surrogate Endpoints to Substantiate Clinical Value Propositions

    Authors: Andrew Satherley, MSc, Senior Consultant, Market Access Consulting; Eric Chang, PharmD, Consultant, Market Access Consulting; Sonika Awasthy, MSc, Senior Business Analyst, Market Access Consulting; Susanne Michel, MD, Vice President and Practice Lead, Market Access Consulting and Executive Director, Center of Excellence for Market Access, Evidera

    Year: 2017

    View

    Whitepaper

    EMA-HTA Parallel Scientific Advice: Early Dialogue to Support Marketing Authorization and Market Access

    Authors: Kirsten Messmer, PhD, RAC, Principal Regulatory Affairs Specialist, PPD; James McCormick, PhD, Senior Director Regulatory Affairs, PPD; Lina Sladkeviciute, MSc, Managing Consultant, Market Access Consulting, Evidera

    Year: 2017

    View
    See More
  • Presentations

    Issue Panel

    IP2: Are We Ready for a Cure? Key Value Demonstration and Policy Considerations for the New Wave of Potentially Curative Therapies

    ISPOR 21st Annual International Meeting – 2016:

    Washington, DC, USA
    21-May-2016

    Authors/Presenters: Faulkner E, Thomas S, Syrek-Jensen T, Daniel G

    Year: 2016

    Poster

    PHP33: Surrogate Endpoints - Can Pricing and Reimbursement Align Across Markets - Or Will the Same Outcome Continue To Be Rewarded Differently for Pricing and Reimbursement?

    ISPOR 21st Annual International Meeting – 2016:

    Washington, DC, USA
    21-May-2016

    Authors/Presenters: Chang E, Satherley A, Awasthy S, Michel S

    Year: 2016

    View

    Poster

    PMD82: 3D Printing is Revolutionizing the Medical Devices World, But Are Payers Ready?

    ISPOR 21st Annual International Meeting – 2016:

    Washington, DC, USA
    21-May-2016

    Authors/Presenters: Nuryyeva E

    Year: 2016

    View
    See More
  • Fact Sheets

    Fact Sheet

    Market Access Consulting Services
    Download

    Fact Sheet

    Payer Expectations of Surrogate Endpoints in Pricing and Reimbursement
    Download

    Fact Sheet

    Navigating the Maze – Market Access for Medical Devices
    Download

    Fact Sheet

    Navigating the Maze – Market Access for Medical Devices: BRAZIL
    Download

    Fact Sheet

    Navigating the Maze – Market Access for Medical Devices: FRANCE
    Download

    Fact Sheet

    Navigating the Maze – Market Access for Medical Devices: GERMANY
    Download

    Fact Sheet

    Navigating the Maze – Market Access for Medical Devices: ITALY
    Download
Back to Top